<p>Aveanna Healthcare Holdings (AVAH) 收到了 BMO Capital 分析师的新买入评级。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>了解 TipRanks 的 <em>ETF</em> AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 的洞察。</li>
</ul>
<p>BMO Capital 给予买入评级的原因包括 Aveanna Healthcare Holdings 最近的财务表现和战略举措。该公司的股价显著上涨，得益于成功的州报销率提高和有效的成本管理，这些因素共同降低了其杠杆比率。</p>
<p>此外，Aveanna 与支付方谈判更高的报销率的策略使其能够为护理人员提供具有竞争力的工资，从而解决家庭护理领域的供需失衡。这种方法不仅吸引了更多的护理人员，还增加了患者数量，有助于实现长期 EBITDA 增长的积极前景。该公司扩大其首选支付方安排的努力以及对基于价值的护理安排的关注进一步支持了 BMO Capital 对其未来表现的乐观看法。</p>
<p>在 11 月 7 日发布的另一份报告中，巴克莱也维持了该股票的买入评级，目标价为 9.00 美元。</p>

AVAH

<p>BMO 资本已对 Aveanna Healthcare Holdings（AVAH）启动买入评级，理由是其强劲的财务表现和战略增长举措。由于州级报销率的提高和有效的成本管理，该公司的股票价值上升，降低了其杠杆比率。Aveanna 通过谈判更高的报销率来确保竞争力的护理人员工资，从而解决家庭护理中的供需问题。这一做法预计将提升患者数量和长期 EBITDA 增长。巴克莱也维持买入评级，目标价为 9.00 美元</p>

<p>Aveanna Healthcare Holdings (AVAH) has received a new Buy rating, initiated by BMO Capital analyst, .</p>
<div class="lb-trans"><p>Aveanna Healthcare Holdings (AVAH) 收到了 BMO Capital 分析师的新买入评级。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的 <em>ETF</em> AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong><em>ETF</em> AI 分析师</strong> 对您关注的 ETF 的洞察。</li>
</ul>
</div><p>BMO Capital has given its Buy rating due to a combination of factors including Aveanna Healthcare Holdings’ recent financial performance and strategic initiatives. The company has seen a significant increase in its stock value, driven by successful state reimbursement rate increases and effective cost management, which have collectively reduced its leverage ratio.</p>
<div class="lb-trans"><p>BMO Capital 给予买入评级的原因包括 Aveanna Healthcare Holdings 最近的财务表现和战略举措。该公司的股价显著上涨，得益于成功的州报销率提高和有效的成本管理，这些因素共同降低了其杠杆比率。</p>
</div><p>Furthermore, Aveanna’s strategy to negotiate higher reimbursement rates with payers allows it to offer competitive wages to caregivers, addressing the supply-demand imbalance in the home-care sector. This approach not only attracts more caregivers but also increases patient volumes, contributing to a positive long-term EBITDA growth outlook. The company’s efforts to expand its preferred payer arrangements and its focus on value-based care arrangements further support BMO Capital’s optimistic view on its future performance.</p>
<div class="lb-trans"><p>此外，Aveanna 与支付方谈判更高的报销率的策略使其能够为护理人员提供具有竞争力的工资，从而解决家庭护理领域的供需失衡。这种方法不仅吸引了更多的护理人员，还增加了患者数量，有助于实现长期 EBITDA 增长的积极前景。该公司扩大其首选支付方安排的努力以及对基于价值的护理安排的关注进一步支持了 BMO Capital 对其未来表现的乐观看法。</p>
</div><p>In another report released on November 7, Barclays also maintained a Buy rating on the stock with a $9.00 price target.</p>
<div class="lb-trans"><p>在 11 月 7 日发布的另一份报告中，巴克莱也维持了该股票的买入评级，目标价为 9.00 美元。</p>
</div>

BMO 资本因 Aveanna Healthcare Holdings 的战略增长和财务表现而发布买入评级